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Abstract
Peri-operative SARS-CoV-2 infection  increases postoperative mortality. The aim of this study was to determine the
optimal duration of planned delay before surgery  in patients who have had SARS-CoV-2 infection . This
international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery
during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection  were compared with those without
previous SARS-CoV-2 infection . The primary outcome measure was 30-day postoperative mortality. Logistic
regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-
CoV-2 infection  to surgery . Among 140,231 patients (116 countries), 3127 patients (2.2%) had a pre-operative
SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection  was 1.5% (95%CI 1.4–
1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery
within 0–2 weeks, 3–4 weeks and 5–6 weeks of the diagnosis (odds ratio (95%CI) 4.1 (3.3–4.8), 3.9 (2.6–5.1) and 3.6
(2.0–5.2), respectively). Surgery  performed ≥ 7 weeks after SARS-CoV-2 diagnosis was associated with a similar
mortality risk to baseline (odds ratio (95%CI) 1.5 (0.9–2.1)). After a ≥ 7 week delay in undertaking surgery  following
SARS-CoV-2 infection , patients with ongoing symptoms had a higher mortality than patients whose symptoms had
resolved or who had been asymptomatic (6.0% (95%CI 3.2–8.7) vs. 2.4% (95%CI 1.4–3.4) vs. 1.3% (95%CI 0.6–2.0),
respectively). Where possible, surgery  should be delayed for at least 7 weeks following  SARS-CoV-2 infection .
Patients with ongoing symptoms ≥ 7 weeks from diagnosis may benefit from further delay. © 2021 The Authors.
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